Impact of utilization of hepatitis C positive organs in liver transplant: Analysis of united network for organ sharing database

Table 1 Demographics of different transplanted groups

	Mean age-donor (yr)	Mean age-recipient (yr)	Males (%)	BMI-recipient	Cold ischemia time	MELD
Group 1	42.72 ± 15.60	54.66 ± 11.63	62.87	29.1 ± 6.12	6.07 ± 2.23	25.22 ± 10.86
Group 2	42.96 ± 15.09	59.08 ± 6.82	75.92	28.67 ± 5.38	6.20 ± 2.46	19.41 ± 11.26
Group 3	40.00 ± 12.41	56.13 ± 10.9	66.8	28.92 ± 6.08	6.45 ± 2.03	21.74 ± 8.39
Group 4	37.71 ± 11.82	58.92 ± 6.76	76.53	28.92 ± 6.08	6.15 ± 2.51	18.24 ± 7.95

Group 1: Both donor and recipient negative for hepatitis C virus (HCV); Group 2: Negative donor and positive recipient for HCV; Group 3: Positive donor and negative recipient for HCV; and Group 4: Both positive donor and recipient for HCV. BMI: Body mass index; MELD: Model for end-stage liver disease.